关注
Dawid Warszycki
Dawid Warszycki
在 if-pan.krakow.pl 的电子邮件经过验证
标题
引用次数
引用次数
年份
A Linear Combination of Pharmacophore Hypotheses as a New Tool in Search of New Active Compounds – An Application for 5-HT1A Receptor Ligands
D Warszycki, S Mordalski, K Kristiansen, R Kafel, I Sylte, Z Chilmonczyk, ...
PLoS One 8 (12), e84510, 2013
462013
Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties
J Staroń, R Kurczab, D Warszycki, G Satała, M Krawczyk, R Bugno, ...
European Journal of Medicinal Chemistry 185, 111857, 2020
352020
Ligand-guided homology modelling of the GABAB2 subunit of the GABAB receptor
T Freyd, D Warszycki, S Mordalski, AJ Bojarski, I Sylte, M Gabrielsen
PLoS One 12 (3), e0173889, 2017
342017
Soloxolone methyl inhibits influenza virus replication and reduces virus-induced lung inflammation
AV Markov, AV Sen’kova, D Warszycki, OV Salomatina, NF Salakhutdinov, ...
Scientific Reports 7 (1), 13968, 2017
312017
From Homology Models to a Set of Predictive Binding Pockets–a 5-HT1A Receptor Case Study
D Warszycki, M Rueda, S Mordalski, K Kristiansen, G Satała, K Rataj, ...
Journal of chemical information and modeling 57 (2), 311-321, 2017
282017
Ligand-based virtual screening in a search for novel anti-HIV-1 chemotypes
A Kurczyk, D Warszycki, R Musiol, R Kafel, AJ Bojarski, J Polanski
Journal of chemical information and modeling 55 (10), 2168-2177, 2015
272015
Straightforward synthesis of 2, 4, 6-trisubstituted 1, 3, 5-triazine compounds targeting cysteine cathepsins K and S
E Plebanek, F Chevrier, V Roy, T Garenne, F Lecaille, D Warszycki, ...
European Journal of Medicinal Chemistry 121, 12-20, 2016
252016
Rational design in search for 5-phenylhydantoin selective 5-HT7R antagonists. Molecular modeling, synthesis and biological evaluation
K Kucwaj-Brysz, D Warszycki, S Podlewska, J Witek, K Witek, ...
European journal of medicinal chemistry 112, 258-269, 2016
242016
Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design
D Warszycki, Ł Struski, M Smieja, R Kafel, R Kurczab
Journal of chemical information and modeling 61 (10), 5054-5065, 2021
222021
Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands–Fluoxetine and fluvoxamine
J Staroń, W Pietruś, R Bugno, R Kurczab, G Satała, D Warszycki, T Lenda, ...
European Journal of Medicinal Chemistry 220, 113533, 2021
202021
Average information content maximization—a new approach for fingerprint hybridization and reduction
M Śmieja, D Warszycki
PloS one 11 (1), e0146666, 2016
172016
Design, synthesis and biological evaluation of 2-substituted-6-[(4-substituted-1-piperidyl) methyl]-1H-benzimidazoles as inhibitors of ebola virus infection
M Bessières, E Plebanek, P Chatterjee, P Shrivastava-Ranjan, M Flint, ...
European Journal of Medicinal Chemistry 214, 113211, 2021
162021
Selective inhibition of human cathepsin S by 2, 4, 6-trisubstituted 1, 3, 5-triazine analogs
Z Tber, M Wartenberg, JE Jacques, V Roy, F Lecaille, D Warszycki, ...
Bioorganic & Medicinal Chemistry 26 (14), 4310-4319, 2018
162018
Sonication‐Assisted Synthesis of (E)‐2‐Methyl‐but‐2‐enyl Nucleoside Phosphonate Prodrugs
M Bessieres, O Sari, V Roy, D Warszycki, AJ Bojarski, SP Nolan, ...
ChemistrySelect 1 (12), 3108-3113, 2016
162016
Asymmetric Clustering Index in a Case Study of 5-HT1A Receptor Ligands
M Śmieja, D Warszycki, J Tabor, AJ Bojarski
PloS one 9 (7), e102069, 2014
152014
Rational design of 5-HT 6 R ligands using a bioisosteric strategy: synthesis, biological evaluation and molecular modelling
J Staroń, D Warszycki, J Kalinowska-Tłuścik, G Satała, AJ Bojarski
RSC advances 5 (33), 25806-25815, 2015
122015
The effect of the intramolecular C–H⋯ O interactions on the conformational preferences of bis-arylsulfones–5-HT 6 receptor antagonists and beyond
J Kalinowska-Tłuścik, J Staroń, A Krawczuk, S Mordalski, D Warszycki, ...
RSC advances 8 (33), 18672-18681, 2018
112018
UV-induced cyclization in myrcene isolated in rigid argon environment: FT-IR and DFT study
A Kaczor, I Reva, D Warszycki, R Fausto
Journal of Photochemistry and Photobiology A: Chemistry 222 (1), 1-9, 2011
112011
Improved HDAC inhibition, stronger cytotoxic effect and higher selectivity against leukemias and lymphomas of novel, tricyclic vorinostat analogues
B Bieszczad, D Garbicz, M Świtalska, MK Dudek, D Warszycki, J Wietrzyk, ...
Pharmaceuticals 14 (9), 851, 2021
102021
In Silico Methods for the Discovery of Orthosteric GABAB Receptor Compounds
LM Evenseth, D Warszycki, AJ Bojarski, M Gabrielsen, I Sylte
Molecules 24 (5), 935, 2019
102019
系统目前无法执行此操作,请稍后再试。
文章 1–20